ANALYSIS OF DENDRITIC CELL LEUKOCYTE COMMON ANTIGEN
树突状细胞白细胞共同抗原的分析
基本信息
- 批准号:3457522
- 负责人:
- 金额:$ 12.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-04-01 至 1996-03-31
- 项目状态:已结题
- 来源:
- 关键词:Langerhans' cell RNase protection assay SDS polyacrylamide gel electrophoresis antigen presenting cell dendritic cells flow cytometry gene expression genetic library genetic manipulation glycoprotein structure glycoproteins human tissue immunoprecipitation laboratory mouse laboratory rat macrophage messenger RNA molecular cloning molecular weight monocyte northern blottings polymerase chain reaction protein sequence surface antigens
项目摘要
The human leukocyte common antigen (LCA) consists of a family of at least
five transmembrane glycoproteins whose differences in primary structure
depend on alternative splicing of mRNA transcripts from a single gene. LCA
expression by all leukocyte subsets and the existence of homologous LCA
molecules among several animal species suggest an important,
evolutionarily-conserved role in leukocyte biology which may be relevant to
the entire spectrum of diseases involving leukocytes. More specifically,
evidence exists that LCA proteins represent a set of cell surface receptors
with protein tyrosine phosphatase activity that are involved in signal
transduction and play a role in lymphoid proliferation, differentiation and
cytotoxicity. This suggests that their study may enhance our understanding
of cell proliferation and differentiation regulatory networks, and may
prove to be clinically relevant to the management of infections, allergic
and autoimmune disorders, allograft rejection, tumor-host interactions and
tumor prevention. The detailed structural characterization of LCAs
obtained from lymphoid subsets has been performed; however, there is little
information available concerning LCA expression by immune-associated
dendritic cells isolated from lymphoid tissue cell suspensions and
peripheral blood. Recently, we have performed epitope mapping studies
which strongly suggest that human Langerhans cells express a novel form of
LCA. This raises the possibility that related mammalian dendritic cells
may also express novel LCA isoforms. We propose to use two-color
immunophenotyping, immunoprecipitation/SDS-PAGE, Northern blotting, PCR
amplification, cDNA sequencing and S1 nuclease protection analysis to study
the structure of LCA isoforms expressed by immune-associated dendritic
cells in the human, mouse and rat. These studies will provide information
concerning the relatedness of various immune-associated dendritic cells to
one another and to other antigen-presenting cells such as
monocytes/macrophages. This research will be the foundation for future
efforts to raise anti-LCA monoclonal antibodies specific for dendritic
cells, and to study the functional effects of cell transfection with
different LCA cDNAs. This, in turn, will allow novel studies of immune-
associated dendritic cell ontogeny/phylogeny and further our understanding
of the functional significance of LCA isoform diversity.
人类白细胞共同抗原(LCA)由一个家族组成,
五种一级结构不同的跨膜糖蛋白
依赖于来自单个基因的mRNA转录物的选择性剪接。 LCA
所有白细胞亚群表达和存在同源LCA
几种动物物种之间的分子表明一个重要的,
白细胞生物学中进化保守的作用,可能与
所有涉及白细胞的疾病 更具体地说,
有证据表明LCA蛋白代表一组细胞表面受体
蛋白酪氨酸磷酸酶活性参与信号传导
转导并在淋巴增殖、分化和
细胞毒 这表明他们的研究可能会增强我们对
细胞增殖和分化调控网络,
证明在临床上与感染、过敏性
和自身免疫性疾病、同种异体移植排斥、肿瘤-宿主相互作用和
肿瘤预防 LCA的详细结构表征
从淋巴亚群中获得;然而,
关于免疫相关的LCA表达的可用信息
从淋巴组织细胞悬浮液中分离的树突状细胞,
外周血 最近,我们进行了表位定位研究,
这强烈表明人类朗格汉斯细胞表达一种新的形式,
LCA。 这就提出了相关的哺乳动物树突细胞
也可以表达新的LCA同种型。 我们建议使用双色
免疫分型、免疫沉淀/SDS-PAGE、北方印迹、PCR
扩增,cDNA测序和S1核酸酶保护分析,以研究
免疫相关树突状细胞表达LCA亚型的结构
人类、小鼠和大鼠的细胞。 这些研究将提供信息
关于各种免疫相关树突状细胞与
彼此和其他抗原呈递细胞,
单核细胞/巨噬细胞。 本研究将为今后的研究奠定基础
致力于提高对树突状细胞特异性的抗LCA单克隆抗体,
细胞,并研究细胞转染的功能效应,
不同的LCA cDNA。 反过来,这将使新的免疫研究-
相关的树突状细胞个体发生/分化,并进一步了解
LCA亚型多样性的功能意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY S WOOD其他文献
GARY S WOOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY S WOOD', 18)}}的其他基金
Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)
c-CBL 在皮肤 T 细胞淋巴瘤 (CTCL) 中的调节机制
- 批准号:
9242573 - 财政年份:2016
- 资助金额:
$ 12.3万 - 项目类别:
Skin Diseases Research Center at the University of Wisconsin
威斯康星大学皮肤病研究中心
- 批准号:
8738104 - 财政年份:2014
- 资助金额:
$ 12.3万 - 项目类别:
Skin Diseases Research Center at the University of Wisconsin
威斯康星大学皮肤病研究中心
- 批准号:
9336234 - 财政年份:2014
- 资助金额:
$ 12.3万 - 项目类别:
PHASE II RHIL-12 IN MF WITH CROSS-OVER TO PHASE I IL-2 ADMINISTERED WITH IL-12
MF 中的 II 期 RHIL-12 与 IL-12 联合给药的 I 期 IL-2 交叉
- 批准号:
7375495 - 财政年份:2005
- 资助金额:
$ 12.3万 - 项目类别:
PHASE II RHIL-12 IN MF WITH CROSS-OVER TO PHASE I IL-2 ADMINISTERED WITH IL-12
MF 中的 II 期 RHIL-12 与 IL-12 联合给药的 I 期 IL-2 交叉
- 批准号:
7204345 - 财政年份:2005
- 资助金额:
$ 12.3万 - 项目类别:
Phase II rhIL-12 in MF with Cross-over to Phase I IL-2 Administered with IL-12
MF 中的 II 期 rhIL-12 与与 IL-12 一起给药的 I 期 IL-2 交叉
- 批准号:
7043896 - 财政年份:2003
- 资助金额:
$ 12.3万 - 项目类别:
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 12.3万 - 项目类别: